WASHINGTON - Federal health officials are recommending a "pause" on the use of the Johnson & Johnson COVID-19 vaccine after six cases of a rare type of blood clotting following vaccination were reported in the United States.The U.S.
Food and Drug Administration and U.S. Centers for Disease Control and Prevention said in a joint statement Tuesday that the pause of the single-dose vaccine is "out of an abundance of caution" while the agencies investigate the cases.The clots were reported in six women in the days after vaccination, in combination with reduced platelet counts."Right now, these adverse events appear to be extremely rare," the statement said. "Treatment of this specific type of blood clot is different from the treatment that.